Cellectis Ads Each Repr 1 Ord Spon盘中异动临近收盘股价大涨5.00%

市场透视2025-06-21

北京时间2025年06月21日04时01分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.47美元/股，成交量6.3719万股，换手率0.06%，振幅7.14%。最近的财报数据显示，该股实现营业收入10.66百万美元，净利润-18.13百万美元，每股收益-0.18美元，毛利--，市盈率-2.16倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2545170951?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-21 04:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2545170951","market":"us","top_or_hot":-1,"title":"Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大涨5.00%","media":"市场透视","content":"<div>\n<p>北京时间2025年06月21日04时01分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.47美元/股，成交量6.3719万股，换手率0.06%，振幅7.14%。最近的财报数据显示，该股实现营业收入10.66百万美元，净利润-18.13百万美元，每股收益-0.18美元，毛利--，市盈率-2.16倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621040144a71518c5&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大涨5.00%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大涨5.00%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-21 04:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621040144a71518c5&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月21日04时01分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.47美元/股，成交量6.3719万股，换手率0.06%，振幅7.14%。最近的财报数据显示，该股实现营业收入10.66百万美元，净利润-18.13百万美元，每股收益-0.18美元，毛利--，市盈率-2.16倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621040144a71518c5&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621040144a71518c5&s=b","article_id":"2545170951","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621040144a71518c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2545170951","pubTimestamp":1750449704,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月21日04时01分，Cellectis Ads Each Repr 1 Ord Spon股票出现异动，股价大幅拉升5.00%。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.51%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞产品候选物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CLLS":"Cellectis S.A."},"translate_title":"Cellectis Ads Each Repr 1 Ord Spon Intraday changes near the close, the stock price rose 5.00%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLLS":0.9},"content_text":"北京时间2025年06月21日04时01分，Cellectis Ads Each Repr 1 Ord Spon（CLLS.us）股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.47美元/股，成交量6.3719万股，换手率0.06%，振幅7.14%。最近的财报数据显示，该股实现营业收入10.66百万美元，净利润-18.13百万美元，每股收益-0.18美元，毛利--，市盈率-2.16倍。机构评级方面，在所有7家参与评级的机构中，71%的券商给予买入建议，29%的券商给予持有建议，无券商给予卖出建议。Cellectis Ads Each Repr 1 Ord Spon股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Immatics N V C/Wts 01/07/2025 (To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Processa Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为1891.53%、1228.28%、468.31%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 (To Pur Com)、Nls Pharmaceutics Ltd C/Wts 02/02/2026(To Pur Com)、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)，振幅分别为84.05%、65.00%、63.48%。Cellectis Ads Each Repr 1 Ord Spon公司简介：Cellectis SA是一家临床阶段生物技术公司，其采用核心专有技术开发基于基因编辑的产品，产品组合包括同种异体嵌合抗原受体T细胞(UCART)、免疫肿瘤学领域的产品候选物以及用于其他治疗适应症的基因编辑的造血干细胞和祖细胞(HSPC)产品候选物。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2545170951","isCrawlerRequest":true}

Cellectis Ads Each Repr 1 Ord Spon盘中异动 临近收盘股价大涨5.00%

精彩评论

Cellectis Ads Each Repr 1 Ord Spon盘中异动临近收盘股价大涨5.00%